Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer

被引：6
|
作者：
Gelissen, Julia H. [1 ]
Huang, Gloria S. [1 ]
机构：
[1] Yale Univ, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
EMT; endometrial cancer; endocrine; estrogen; diabetes; glucose; metformin; ESTROGEN-RECEPTOR-ALPHA; E-CADHERIN; GENE-EXPRESSION; CELLS; GENISTEIN; PROTEIN; PROLIFERATION; PROGRESSION; MIGRATION; CHEMICALS;
D O I：
10.3389/fonc.2022.914405
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The epithelial mesenchymal transition (EMT) is the process by which cancer cells of epithelial origin, including endometrial cancer, acquire a mesenchymal phenotype with enhanced migratory and invasive capacity, to facilitate metastasis. The regulation of EMT is tissue-specific, and in endometrial cancer, endocrine signaling pathways serve as critical regulators of EMT. The intersections of endocrine signaling and EMT highlight potential avenues for therapeutic intervention to target cancer metastasis with the aim of reduced mortality.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process
    Lee, Hae-Miru
    Hwang, Kyung-A
    Choi, Kyung-Chul
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 457 (0C) : 103 - 113
  • [2] Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review)
    Al Saleh, Sanaa
    Sharaf, Leyla H.
    Luqmani, Yunus A.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (05) : 1197 - 1217
  • [3] In vitro effects of osteopontin on endometrial cancer cells and signaling pathways in epithelial-mesenchymal transition
    Kardelen, Evrim
    Atakul, Tolga
    Yuksel, Hasan
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (05) : 152 - 161
  • [4] Epithelial-mesenchymal Transition and Cancer Stem Cells in Endometrial Cancer
    Supernat, Anna
    Lapinska-Szumczyk, Sylwia
    Majewska, Hanna
    Gulczynski, Jacek
    Biernat, Wojciech
    Wydra, Dariusz
    Zaczek, Anna J.
    ANTICANCER RESEARCH, 2013, 33 (12) : 5461 - 5469
  • [5] Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer
    Bhattacharya, Debasmita
    Scime, Anthony
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [6] Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
    van der Horst, Paul H.
    Wang, Yongyi
    Vandenput, Ingrid
    Kuhne, Liesbeth C.
    Ewing, Patricia C.
    van IJcken, Wilfred F. J.
    van der Zee, Marten
    Amant, Frederic
    Burger, Curt W.
    Blok, Leen J.
    PLOS ONE, 2012, 7 (01):
  • [7] Molecular Landscape of the Epithelial-Mesenchymal Transition in Endometrioid Endometrial Cancer
    Oplawski, Marcin
    Nowakowski, Robert
    Srednicka, Agata
    Ochnik, Dominika
    Grabarek, Beniamin Oskar
    Boron, Dariusz
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [8] FGFR-2 and Epithelial-Mesenchymal Transition in Endometrial Cancer
    Adamczyk-Gruszka, Olga
    Horecka-Lewitowicz, Agata
    Gruszka, Jakub
    Wawszczak-Kasza, Monika
    Strzelecka, Agnieszka
    Lewitowicz, Piotr
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [9] Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer
    Huang, Ruby Yun-Ju
    Chung, Vin Yee
    Thiery, Jean Paul
    CURRENT DRUG TARGETS, 2012, 13 (13) : 1649 - 1653
  • [10] Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer
    Sadlecki, Pawel
    Jozwicki, Jakub
    Antosik, Paulina
    Walentowicz-Sadlecka, Malgorzata
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
12345